BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21105289)

  • 1. Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial.
    Richter C; Hinzpeter A; Schmidt F; Kienast T; Preuss UW; Plenge T; Heinz A; Schaefer M
    J Clin Psychopharmacol; 2010 Dec; 30(6):720-5. PubMed ID: 21105289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
    Müller CA; Schäfer M; Schneider S; Heimann HM; Hinzpeter A; Volkmar K; Förg A; Heinz A; Hein J
    Pharmacopsychiatry; 2010 Jul; 43(5):184-9. PubMed ID: 20503149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
    Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.
    Richter C; Effenberger S; Bschor T; Bonnet U; Haasen C; Preuss UW; Heinz A; Förg A; Volkmar K; Glauner T; Schaefer M
    J Clin Psychopharmacol; 2012 Aug; 32(4):558-62. PubMed ID: 22722516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.
    Cereghino JJ; Biton V; Abou-Khalil B; Dreifuss F; Gauer LJ; Leppik I
    Neurology; 2000 Jul; 55(2):236-42. PubMed ID: 10908898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam as adjunctive therapy for acute alcohol withdrawal syndrome in hospitalized patients.
    Youland KM; Miller RF; Mahoney LJ; Borgert AJ; Gundrum JD
    J Clin Psychopharmacol; 2014 Dec; 34(6):704-8. PubMed ID: 25144138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.
    Fertig JB; Ryan ML; Falk DE; Litten RZ; Mattson ME; Ransom J; Rickman WJ; Scott C; Ciraulo D; Green AI; Tiouririne NA; Johnson B; Pettinati H; Strain EC; Devine E; Brunette MF; Kampman K; A Tompkins D; Stout R;
    Alcohol Clin Exp Res; 2012 Aug; 36(8):1421-30. PubMed ID: 22324516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome.
    Girish K; Vikram Reddy K; Pandit LV; Pundarikaksha HP; Vijendra R; Vasundara K; Manjunatha R; Nagraj M; Shruthi R
    Biomed J; 2016 Feb; 39(1):72-80. PubMed ID: 27105601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of levetiracetam and tiapride for outpatient alcohol detoxification: a case series.
    Müller CA; Schäfer M; Banas R; Heimann HM; Volkmar K; Förg A; Heinz A; Hein J
    J Addict Med; 2011 Jun; 5(2):153-6. PubMed ID: 21769061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A; Martin FC
    Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.
    Shorvon SD; Löwenthal A; Janz D; Bielen E; Loiseau P
    Epilepsia; 2000 Sep; 41(9):1179-86. PubMed ID: 10999557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
    Lee JA; Duby JJ; Cocanour CS
    Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859
    [No Abstract]   [Full Text] [Related]  

  • 18. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam.
    Addolorato G; Leggio L; Abenavoli L; Agabio R; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Am J Med; 2006 Mar; 119(3):276.e13-8. PubMed ID: 16490478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in the treatment of alcohol dependence: toward the end of the story?
    Le Strat Y
    Alcohol Clin Exp Res; 2012 Aug; 36(8):1309-10. PubMed ID: 22823576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial.
    Caputo F; Skala K; Mirijello A; Ferrulli A; Walter H; Lesch O; Addolorato G
    CNS Drugs; 2014 Aug; 28(8):743-52. PubMed ID: 24996524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.